The company’s product, NTX1088, blocks the harmful overexpression of PVR proteins, which occurs in tumors caused by lung, breast, throat and other cancers.
New drug candidate could boost potential of immunotherapy israel21c.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from israel21c.org Daily Mail and Mail on Sunday newspapers.
New Israeli Drug Boosts Potential for Immunotherapy unitedwithisrael.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from unitedwithisrael.org Daily Mail and Mail on Sunday newspapers.